LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 93

Search options

  1. Article ; Online: Redescription of the brackish water crab Ptychognathus glaber Stimpson, 1858 based on the topotypic material from the Ogasawara Islands and new record of P. lipkei N.K. Ng, 2010 from Japan (Decapoda: Brachyura: Varunidae).

    Komai, Tomoyuki / Maenosono, Tadafumi / Saeki, Toshifumi / Naruse, Tohru

    Zootaxa

    2021  Volume 5048, Issue 1, Page(s) 58–76

    Abstract: Examination of material from various Japanese localities clarified that the estuarine crab Ptychognathus glaber Stimpson, 1858 is possibly restricted to the Ogasawara Islands, Japan. Specimens from the Ryukyu Islands, thought to represent P. glaber, ... ...

    Abstract Examination of material from various Japanese localities clarified that the estuarine crab Ptychognathus glaber Stimpson, 1858 is possibly restricted to the Ogasawara Islands, Japan. Specimens from the Ryukyu Islands, thought to represent P. glaber, actually represent P. lipkei N.K. Ng, 2010 instead, previously known only from Cebu, the Philippines. Ptychognathus glaber is redescribed in detail, and differentiating characters between it and P. lipkei are reassessed. Previous literature records of P. glaber are reviewed in the light of our findings. Genetic analysis using partial sequences of the mitochondrial 16S rRNA gene suggests that P. glaber is genetically closer to P. ishii Sakai, 1939 than to P. lipkei, and thus P. ishii is also compared morphologically with P. glaber.
    MeSH term(s) Animals ; Brachyura/genetics ; Islands ; Japan ; Philippines ; RNA, Ribosomal, 16S/genetics ; Saline Waters
    Chemical Substances RNA, Ribosomal, 16S
    Language English
    Publishing date 2021-10-05
    Publishing country New Zealand
    Document type Journal Article
    ISSN 1175-5334
    ISSN (online) 1175-5334
    DOI 10.11646/zootaxa.5048.1.3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Rapid cyclic fluctuations in blood pressure during two surgeries associated with pheochromocytoma: a case report.

    Watanabe, Tomoyuki / Miyoshi, Hirotsugu / Nakamura, Ryuji / Otsuki, Sachiko / Saeki, Noboru / Tsutsumi, Yasuo M

    JA clinical reports

    2022  Volume 8, Issue 1, Page(s) 80

    Abstract: Background: We measured catecholamine levels during periodic blood pressure fluctuations in patients with pheochromocytoma.: Case presentation: A 43-year-old man presented with periodic blood pressure fluctuations during surgery for a renal pelvic ... ...

    Abstract Background: We measured catecholamine levels during periodic blood pressure fluctuations in patients with pheochromocytoma.
    Case presentation: A 43-year-old man presented with periodic blood pressure fluctuations during surgery for a renal pelvic tumor. His blood levels of catecholamines (ng/mL) changed dramatically over a short time during blood pressure fluctuations: adrenaline 0.36 to 3.22, noradrenaline 0.47 to 1.98, and dopamine 0.02. After the diagnosis of pheochromocytoma, oral treatment with doxazosin 2 mg/day was administered, and left adrenalectomy was performed 4 months after the initial surgery. Periodic circulation fluctuations occurred after tracheal intubation at the time of anesthesia induction, but the degree of fluctuation was smaller than that of the first surgery.
    Conclusions: The data suggest that the periodic blood pressure fluctuations in pheochromocytoma patients are caused by changes in blood catecholamine levels. Our data suggests that alpha blockers may also be effective against the cyclic fluctuations that occur in patients with pheochromocytoma.
    Language English
    Publishing date 2022-10-05
    Publishing country Germany
    Document type Journal Article
    ISSN 2363-9024
    ISSN (online) 2363-9024
    DOI 10.1186/s40981-022-00569-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Zinc supplementation with polaprezinc was associated with improvements in albumin, prothrombin time activity, and hemoglobin in chronic liver disease.

    Abiru, Seigo / Kugiyama, Yuki / Suehiro, Tomoyuki / Motoyoshi, Yasuhide / Saeki, Akira / Nagaoka, Shinya / Yamasaki, Kazumi / Komori, Atsumasa / Yatsuhashi, Hiroshi

    Journal of clinical biochemistry and nutrition

    2023  Volume 74, Issue 2, Page(s) 162–168

    Abstract: Zinc deficiency occurs in a variety of diseases, including chronic liver disease (CLD). We investigated the correlation between zinc levels and biochemical and hematological tests in CLD and the effect of zinc supplementation with polaprezinc on these ... ...

    Abstract Zinc deficiency occurs in a variety of diseases, including chronic liver disease (CLD). We investigated the correlation between zinc levels and biochemical and hematological tests in CLD and the effect of zinc supplementation with polaprezinc on these values. The first study (Study 1) was a retrospective observational study of 490 patients with CLD not receiving zinc supplementation, with data available from September 2009 to August 2021. Univariate and multiple regression analysis showed that serum zinc levels correlated most strongly with albumin (Alb) and also significantly with prothrombin time activity (PT%) and hemoglobin (Hb). A subsequent study (Study 2) focused on patients with advanced CLD who used polaprezinc for more than 90 days between January 2005 and August 2021. Using a self-controlled design with the 6-month period prior to polaprezinc as the control period, comparisons showed that Alb (
    Language English
    Publishing date 2023-11-10
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 632945-7
    ISSN 1880-5086 ; 0912-0009
    ISSN (online) 1880-5086
    ISSN 0912-0009
    DOI 10.3164/jcbn.23-89
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: [Influence of Pleural Adhesions on Thoracoscopic Surgeries for Malignant Lung Tumors].

    Kobayashi, Naohiro / Kawamura, Tomoyuki / Yanagihara, Takahiro / Saeki, Yusuke / Kikuchi, Shinji / Goto, Yukinobu / Sato, Yukio

    Kyobu geka. The Japanese journal of thoracic surgery

    2021  Volume 74, Issue 7, Page(s) 509–513

    Abstract: In the present study, influences of pleural adhesions on thoracoscopic lung surgeries were investigated. A total of 666 consecutive patients who had undergone thoracoscopic surgeries for lung malignant tumors were retrospectively analyzed. Pleural ... ...

    Abstract In the present study, influences of pleural adhesions on thoracoscopic lung surgeries were investigated. A total of 666 consecutive patients who had undergone thoracoscopic surgeries for lung malignant tumors were retrospectively analyzed. Pleural adhesions were present intraoperatively in 289 cases, of which 6 required conversion to thoracotomy due to the adhesions. The influences of pleural adhesions on the perioperative period were comparatively large under following conditions (level-A); the adhesion-type was tight which meant lung and pleural wall sticked closely even if lung collapse was encouraged, the strength was middle( required sharp-dissection) or strong( hard to dissect between visceral and parietal pleura), and the range was more than 10% of total pleural surface. Significant influences of the level-A of pleural adhesions were as follows;prolonged operation time in all procedures, frequent intraoperative lung fistula and prolonged pleural drainage period in wedge resections, and increased blood loss, intraoperative and postoperative lung fistula with prolonged pleural drainage time and postoperative hospitalization period in lobectomy. Other postoperative complications (pneumonia, empyema, exacerbation of interstitial pneumonitis, and arrhythmias) were not associated with pleural adhesions. Careful dissection procedure for pleural adhesions that minimize damage of visceral pleura would be the most important.
    MeSH term(s) Humans ; Lung Neoplasms/surgery ; Pleura ; Pleural Diseases/etiology ; Pleural Diseases/surgery ; Retrospective Studies ; Thoracic Surgery, Video-Assisted ; Thoracoscopy
    Language Japanese
    Publishing date 2021-07-01
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 603899-2
    ISSN 0021-5252
    ISSN 0021-5252
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker for Intravascular Large B-cell Lymphoma: Immunohistochemical Analysis of 152 Pathology Specimens From 88 Patients.

    Saka, Manduwa / Fujimoto, Masakazu / Mizoguchi, Kai / Tsujimura, Marina / Saeki, Miho / Hirata, Masahiro / Shibuya, Shinsuke / Odani, Kentaro / Sakurai, Takaki / Yuba, Yoshiaki / Moriyoshi, Koki / Nakajima, Naoki / Sumiyoshi, Shinji / Kono, Fumihiko / Ono, Kazuo / Shirase, Tomoyuki / Watanabe, Chihiro / Yoshizawa, Akihiko / Haga, Hironori

    The American journal of surgical pathology

    2024  

    Abstract: Intravascular large B-cell lymphoma (IVLBCL) is a rare type of aggressive extranodal large B-cell lymphoma characterized by the selective growth of lymphoma cells within the lumina of blood vessels, particularly capillaries. IVLBCL lacks mass formation, ... ...

    Abstract Intravascular large B-cell lymphoma (IVLBCL) is a rare type of aggressive extranodal large B-cell lymphoma characterized by the selective growth of lymphoma cells within the lumina of blood vessels, particularly capillaries. IVLBCL lacks mass formation, and its diagnosis can be challenging. We analyzed the utility of insulin-like growth factor II mRNA-binding protein 3 (IMP3) immunohistochemistry for IVLBCL diagnosis in various organs. Double staining with paired box 5 (PAX5) was performed for validation. Overall, 152 pathological specimens (111 positive and 41 negative for IVLBCL) obtained from 88 patients with a diagnosis of IVLBCL were stained for IMP3 and IMP3/PAX5. As negative controls, 40 pathology specimens from 38 patients with no history of IVLBCL or other B-cell lymphomas were stained for IMP3, which comprised 31 benign pathological specimens from 29 patients in whom malignancy was suspected, 7 cases of appendicitis with intravascular and/or intralymphatic lymphoid proliferations, and 2 cases of intravascular natural killer/T-cell lymphoma. All mononuclear cells with cytoplasmic staining were considered positive for IMP3 expression, but expression restricted to germinal center B cells was excluded from evaluation. All 111 IVLBCL pathological specimens were positive for IMP3 and IMP3/PAX5. In addition, 11 of the 41 specimens originally diagnosed as IVLBCL-negative showed IMP3/PAX5 double-positive cells, raising the suspicion of IVLBCL. However, of the 40 negative control samples, IMP3-positive non-germinal center B cells were detected in only 2 samples (P= 0.0131) and no intravascular IMP3-positive B cells suspicious for IVLBCL were identified. Altogether, IMP3 immunohistochemistry is a highly sensitive marker of IVLBCL and can be a helpful adjunct for IVLBCL diagnosis.
    Language English
    Publishing date 2024-03-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 752964-8
    ISSN 1532-0979 ; 0147-5185
    ISSN (online) 1532-0979
    ISSN 0147-5185
    DOI 10.1097/PAS.0000000000002214
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Subanesthetic Dose of Propofol Activates the Reward System in Rats.

    Nagata, Isao / Sasaki, Mika / Miyazaki, Tomoyuki / Saeki, Kensuke / Ogawa, Ken-Ichi / Kamiya, Yoshinori

    Anesthesia and analgesia

    2021  Volume 135, Issue 2, Page(s) 414–426

    Abstract: Background: Propofol has addictive properties, even with a single administration, and facilitates dopamine secretion in the nucleus accumbens (NAc). Activation of the dopaminergic circuits of the midbrain reward system, including the ventral tegmental ... ...

    Abstract Background: Propofol has addictive properties, even with a single administration, and facilitates dopamine secretion in the nucleus accumbens (NAc). Activation of the dopaminergic circuits of the midbrain reward system, including the ventral tegmental area (VTA) and NAc, plays a crucial role in addiction. However, the effects of propofol on synaptic transmission and biochemical changes in the VTA-NAc circuit remain unclear.
    Methods: We investigated the effects of subanesthetic doses of propofol on rat VTA neurons and excitatory synaptic transmission in the NAc using slice patch-clamp experiments. Using immunohistochemistry and western blot analyses, we evaluated the effects of intraperitoneal propofol administration on the expression of addiction-associated transcription factor ΔFosB (truncated form of the FBJ murine osteosarcoma viral oncogene homolog B protein) in the NAcs in 5-week-old rats.
    Results: In the current-clamp mode, a subanesthetic dose (0.5-5 µmol/L) of propofol increased the action potential frequency in about half the VTA neurons (excited neurons: control: 9.4 ± 3.0 Hz, propofol 0.5 µmol/L: 21.5 ± 6.0 Hz, propofol 5 µmol/L: 14.6 ± 5.3 Hz, wash: 2.0 ± 0.7 Hz, n = 14/27 cells; unchanged/suppressed neurons: control: 1.68 ± 0.94 Hz, propofol 0.5 µmol/L: 1.0 ± 0.67 Hz, propofol 5 µmol/L: 0.89 ± 0.87 Hz, wash: 0.16 ± 0.11 Hz, n = 13/27 cells). In the voltage-clamp mode, about half the VTA principal neurons showed inward currents with 5 µmol/L of propofol (inward current neurons: control: -20.5 ± 10.0 pA, propofol 0.5 µmol/L: -62.6 ± 14.4 pA, propofol 5 µmol/L: -85.2 ± 18.3 pA, propofol 50 µmol/L: -17.1 ± 39.2 pA, washout: +30.5 ± 33.9 pA, n = 6/11 cells; outward current neurons: control: -33.9 ± 14.6 pA, propofol 0.5 µmol/L: -29.5 ± 16.0 pA, propofol 5 µmol/L: -0.5 ± 20.9 pA, propofol 50 µmol/L: +38.9 ± 18.5 pA, washout: +40.8 ± 32.1 pA, n = 5/11 cells). Moreover, 0.5 µmol/L propofol increased the amplitudes of evoked excitatory synaptic currents in the NAc, whereas >5 µmol/L propofol decreased them (control: 100.0 ± 2.0%, propofol 0.5 µmol/L: 118.4 ± 4.3%, propofol 5 µmol/L: 98.3 ± 3.3%, wash [within 10 min]: 70.7 ± 3.3%, wash [30 minutes later]: 89.9 ± 2.5%, n = 13 cells, P < .001, Dunnett's test comparing control and propofol 0.5 µmol/L). Intraperitoneally administered subanesthetic dose of propofol increased ΔFosB expression in the NAc, but not in VTA, 2 and 24 hours after administration, compared with the Intralipid control group (propofol 2 hours: 0.94 ± 0.15, 24 hours: 0.68 ± 0.07; Intralipid 2 hours: 0.40 ± 0.03, 24 hours: 0.37 ± 0.06, P = .0002 for drug in the 2-way analysis of variance).
    Conclusions: Even a single administration of a subanesthetic dose of propofol may cause rewarding change in the central nervous system. Thus, there is a potential propofol rewarding effect among patients receiving anesthesia or sedation with propofol, as well as among health care providers exposed to propofol.
    MeSH term(s) Animals ; Mice ; Nucleus Accumbens ; Propofol/metabolism ; Propofol/pharmacology ; Rats ; Reward ; Synaptic Transmission ; Ventral Tegmental Area/metabolism
    Chemical Substances Propofol (YI7VU623SF)
    Language English
    Publishing date 2021-12-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80032-6
    ISSN 1526-7598 ; 0003-2999
    ISSN (online) 1526-7598
    ISSN 0003-2999
    DOI 10.1213/ANE.0000000000005847
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Relationship between changes in pulmonary function and patient-reported outcomes of lung cancer surgery.

    Ichimura, Hideo / Kobayashi, Keisuke / Gosho, Masahiko / Sekine, Yasuharu / Sugai, Kazuto / Kawamura, Tomoyuki / Saeki, Yusuke / Suzuki, Hisashi / Kobayashi, Naohiro / Goto, Yukinobu / Sato, Yukio

    Surgery today

    2023  Volume 54, Issue 2, Page(s) 195–204

    Abstract: Purpose: To investigate the relationship between changes in pulmonary function (PF) and patient-reported outcomes (PROs) of lung cancer surgery.: Methods: We recruited 262 patients who underwent lung resection for lung cancer, to evaluate the PROs, ... ...

    Abstract Purpose: To investigate the relationship between changes in pulmonary function (PF) and patient-reported outcomes (PROs) of lung cancer surgery.
    Methods: We recruited 262 patients who underwent lung resection for lung cancer, to evaluate the PROs, using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30 and the Lung Cancer 13-question supplement (LC13). The patients underwent PF tests and PRO assessments preoperatively (Pre) and 1 year after surgery (Y1). Changes were calculated by subtracting the value at Pre from the value at Y1. We set two cohorts: patients under the ongoing protocol (Cohort 1) and patients who were eligible for lobectomy with clinical stage I lung cancer (Cohort 2).
    Results: Cohorts 1 and 2 comprised 206 and 149 patients, respectively. In addition to dyspnea, changes in PF were also correlated with scores for global health status, physical and role function scores, fatigue, nausea and vomiting, pain, and financial difficulties. Absolute correlation coefficient values ranged from 0.149 to 0.311. Improvement of emotional and social function scores was independent of PF. Sublobar resection preserved PF more than lobectomy did. Wedge resection mitigated dyspnea in both cohorts.
    Conclusion: The correlation between PF and PROs was found to be weak; therefore, further studies are needed to improve the patient's postoperative experience.
    MeSH term(s) Humans ; Lung Neoplasms/drug therapy ; Quality of Life ; Lung ; Patient Reported Outcome Measures ; Dyspnea/etiology ; Surveys and Questionnaires
    Language English
    Publishing date 2023-06-12
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 1115435-4
    ISSN 1436-2813 ; 0941-1291
    ISSN (online) 1436-2813
    ISSN 0941-1291
    DOI 10.1007/s00595-023-02716-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Three-dimensional analysis reveals a high incidence of lung adenocarcinoma in the upper region.

    Kawamura, Tomoyuki / Sekine, Yasuharu / Sugai, Kazuto / Yanagihara, Takahiro / Saeki, Yusuke / Kitazawa, Shinsuke / Kobayashi, Naohiro / Goto, Yukinobu / Ichimura, Hideo / Ohigashi, Tomohiro / Maruo, Kazushi / Sato, Yukio

    Surgery today

    2023  

    Abstract: Purpose: The lung is a unique organ with a ventilation-perfusion mismatch, which can cause inhomogeneous incidence rates of lung cancer depending on the location in the lung. We aimed to evaluate the incidence of lung adenocarcinoma in each lobe by ... ...

    Abstract Purpose: The lung is a unique organ with a ventilation-perfusion mismatch, which can cause inhomogeneous incidence rates of lung cancer depending on the location in the lung. We aimed to evaluate the incidence of lung adenocarcinoma in each lobe by analyzing the incidence per unit volume, to evaluate the incidence without being affected by differences in the size of each lobe or in the size of the lungs between individuals.
    Methods: The number of adenocarcinomas in each lobe was counted. Lung volumes were measured using a three-dimensional computer workstation. The tumor incidence per unit volume was analyzed based on the number of tumors in each lobe.
    Results: The number of tumors per unit volume was 0.467 in the right upper lobe (RUL), 0.182 in the right middle lobe, 0.209 in the right lower lobe, 0.306 in the left upper segment (LUS), 0.083 in the left lingular segment, and 0.169 in the left lower lobe. The tumor incidence rate of RUL + LUS was 2.269 times that of the other lobes, a value that was significantly higher when using the bootstrap method (p < 0.001).
    Conclusions: The incidence of adenocarcinoma per unit volume in both upper lobes was higher than that in other lobes.
    Language English
    Publishing date 2023-12-06
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 1115435-4
    ISSN 1436-2813 ; 0941-1291
    ISSN (online) 1436-2813
    ISSN 0941-1291
    DOI 10.1007/s00595-023-02776-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Correction: Involvement of C-terminal truncation mutation of kinesin-5 in resistance to kinesin-5 inhibitor.

    Saeki, Eri / Yasuhira, Shinji / Shibazaki, Masahiko / Tada, Hiroshi / Doita, Minoru / Masuda, Tomoyuki / Maesawa, Chihaya

    PloS one

    2019  Volume 14, Issue 2, Page(s) e0212821

    Abstract: This corrects the article DOI: 10.1371/journal.pone.0209296.]. ...

    Abstract [This corrects the article DOI: 10.1371/journal.pone.0209296.].
    Language English
    Publishing date 2019-02-20
    Publishing country United States
    Document type Published Erratum
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0212821
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Multicenter Randomized Open-Label Phase II Clinical Study Comparing Outcomes of NK105 and Paclitaxel in Advanced or Recurrent Breast Cancer.

    Kosaka, Yoshimasa / Saeki, Toshiaki / Takano, Toshimi / Aruga, Tomoyuki / Yamashita, Toshinari / Masuda, Norikazu / Koibuchi, Yukio / Osaki, Akihiko / Watanabe, Junichiro / Suzuki, Ryu

    International journal of nanomedicine

    2022  Volume 17, Page(s) 4567–4578

    Abstract: Background: NK105 is a paclitaxel (PTX)-incorporating "core-shell-type" polymeric micellar nanoparticle formulation composed of block copolymers (polyethylene glycol and a polyamino acid). The efficacy and safety of NK105 and paclitaxel in advanced or ... ...

    Abstract Background: NK105 is a paclitaxel (PTX)-incorporating "core-shell-type" polymeric micellar nanoparticle formulation composed of block copolymers (polyethylene glycol and a polyamino acid). The efficacy and safety of NK105 and paclitaxel in advanced or recurrent breast cancer have never been compared at equivalent dose levels.
    Patients and methods: Patients were randomly assigned to either NK105 or PTX in a 1:1 ratio. The study drug was administered on Day 1, 8, and 15 of a 28-day cycle with 80 mg/m
    Results: A total of 123 patients (NK105, n=62; PTX, n=61) received one of the two drugs. There was no significant difference in ORR, the median PFS, or OS (NK105 group: 41.9%, 9.1, and 27.5 months, respectively; PTX group: 45.9%, 7.8, and 32.4 months, respectively). Neutropenia occurred more frequently in the NK105 group, but most patients did not require granulocyte-colony stimulating factor or dose-reduction. The median time to onset of peripheral sensory neuropathy (PSN) in the NK105 group was significantly longer than that in the PTX group (p=0.001), and PSN (≥ grade 3) was not observed in the NK105 group.
    Conclusion: Weekly NK105 administration was well-tolerated. Efficacy was similar in both groups. The PSN profile was better in the NK105 group.
    MeSH term(s) Antineoplastic Combined Chemotherapy Protocols ; Breast Neoplasms/drug therapy ; Colony-Stimulating Factors/therapeutic use ; Female ; Humans ; Paclitaxel/analogs & derivatives ; Paclitaxel/therapeutic use ; Peripheral Nervous System Diseases/chemically induced ; Polyethylene Glycols/therapeutic use ; Polymers
    Chemical Substances Colony-Stimulating Factors ; NK105 ; Polymers ; Polyethylene Glycols (3WJQ0SDW1A) ; Paclitaxel (P88XT4IS4D)
    Language English
    Publishing date 2022-09-27
    Publishing country New Zealand
    Document type Clinical Trial, Phase II ; Journal Article ; Multicenter Study ; Randomized Controlled Trial
    ZDB-ID 2364941-0
    ISSN 1178-2013 ; 1176-9114
    ISSN (online) 1178-2013
    ISSN 1176-9114
    DOI 10.2147/IJN.S372477
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top